REDUÇÃO DE CÉLULAS DENDRÍTICAS PLASMOCITOIDES É COMUM EM PACIENTES COM MIELOFIBROSE E ESTÁ ASSOCIADA A PROGNÓSTICO ADVERSO

Autor: NAC Silva, FP Guirao, MCR Barbosa, DAO Bernal, LC Vassalli, AF Sandes

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S191- (2023)

Introdução e objetivos: As células dendríticas plasmocitoides (pDCs) são um tipo de célula imune que faz parte do sistema imunológico inato. Elas desempenham um papel fundamental na defesa do corpo contra infecções virais, sendo capazes de d

Externí odkaz: https://doaj.org/article/449f637f2fea4385b6a2808204869899

O VALOR DA DOENÇA RESIDUAL MENSURÁVEL POR CITOMETRIA DE FLUXO NA LEUCEMIA MIELOIDE AGUDA: DO TRATAMENTO QUIMIOTERÁPICO AO PÓS-TRANSPLANTE

Autor: MLBF Dourado, G Matias, AF Sandes, MV Goncalves, VC Molla, FP Guirao, MCR Barbosa, M Yamamoto, CA Rodrigues, FR Kerbauy

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S169-S170 (2021)

Introdução: A doença residual mensurável (DRM) é um marcador prognóstico independente em pacientes com LMA, auxiliando na estratificação de risco e plano terapêutico. Entretanto, a padronização da técnica e associação com outros parâme

Externí odkaz: https://doaj.org/article/f140d370021c49b089da6b70eb354883

Natural killer cells 56 ^bright 16 ^- have higher counts in the umbilical cord blood than in the adult peripheral blood.

Autor: de Molla VC; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Hospital 9 de Julho, São Paulo, Brazil., Barbosa MCR; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil., Junior AM; Hospital 9 de Julho, São Paulo, Brazil., Gonçalves MV; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil., Guirao EKF; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil., Yamamoto M; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil., Arrais-Rodrigues C; Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Hospital 9 de Julho, São Paulo, Brazil.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2023 Oct-Dec; Vol. 45 (4), pp. 419-427. Date of Electronic Publication: 2022 Aug 19.

Oral administration of Hsp65-producing Lactococcus lactis attenuates allergic asthma in a murine model.

Autor: de Lacerda LB; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Rios WM; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Masson AP; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Brandão IT; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Milani TM; Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Borges MC; Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Ramalho LNZ; Department of Pathology Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Barbosa MCR; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Miyoshi A; Department of Ecology, Genetics and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil., Silva CL; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Publikováno v: Journal of applied microbiology [J Appl Microbiol] 2021 Jun; Vol. 130 (6), pp. 2075-2086. Date of Electronic Publication: 2020 Nov 22.

Parasite Infections, Allergy and Asthma: A Role for Tropomyosin in Promoting Type 2 Immune Responses.

Autor: Sousa-Santos ACAF; Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Moreno AS; Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Santos ABR; Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; Instituto de Ciências da Saúde ICS, Universidade Paulista UNIP Campus Campinas, Campinas, Brazil., Barbosa MCR; Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; Escola de Medicina e Ciências da Saúde, Universidade Anhembi Morumbi - Laureate International Universities Campus Piracicaba, Piracicaba, Brazil., Aragon DC; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Sales VSF; Department of Immunology, Federal University of Rio Grande do Norte, Natal, Brazil., Arruda LK; Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, karla@fmrp.usp.br.

Publikováno v: International archives of allergy and immunology [Int Arch Allergy Immunol] 2020; Vol. 181 (3), pp. 221-227. Date of Electronic Publication: 2019 Dec 19.